Cargando…
Chemotherapy options versus “novel” therapies: how should we treat patients with malignant pleural mesothelioma
Today there are several options for the treatment of patients with malignant pleural mesothelioma (MPM). The therapeutic arsenal has expanded from only chemotherapy with or without surgery in selected cases to a variety of new compounds that target the malignant cell or its micro-environment. Immuno...
Autores principales: | Disselhorst, Maria J., Baas, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082258/ https://www.ncbi.nlm.nih.gov/pubmed/32206573 http://dx.doi.org/10.21037/tlcr.2020.01.16 |
Ejemplares similares
-
How I treat malignant pleural mesothelioma
por: Viscardi, Giuseppe, et al.
Publicado: (2020) -
Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma
por: Migliore, Marcello, et al.
Publicado: (2021) -
Immunotherapy in Malignant Pleural Mesothelioma
por: de Gooijer, Cornedine J., et al.
Publicado: (2020) -
An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
por: Davis, Alexander, et al.
Publicado: (2022) -
Malignant Pleural Mesothelioma Nodal Status: Where Are We at?
por: Ricciardi, Sara, et al.
Publicado: (2021)